Prot# AVF3255s: A Phase II Trial of Weekly Gemcitabine and Bevacizumab (Avastin ) in Combination with Abdominal Radiation Therapy in Patients with Localized Pancreatic Cancer (NU Prot# NU 04I6)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/4/05 → 11/9/10

Funding

  • Genentech, Inc (AVF3255s)